Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""DENSITY"" wg kryterium: Temat


Starter badań:

Tytuł:
A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence.
Autorzy:
Ward LM; Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jan 25; Vol. 14, pp. 1266986. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Osteoporosis*/therapy
Osteoporosis*/drug therapy
Fractures, Bone*/drug therapy
Bone Density Conservation Agents*/therapeutic use
Humans ; Adolescent ; Child ; Adult ; Bone Density ; Risk Factors
Czasopismo naukowe
Tytuł:
Design, Synthesis, and Anti-Osteoporotic Characterization of Arginine N -Glycosylated Teriparatide Analogs via the Silver-catalyzed Solid-Phase Glycosylation Strategy.
Autorzy:
Cong W; School of Medicine, Shanghai University, Shanghai 200444, China.
Shen H; School of Medicine, Shanghai University, Shanghai 200444, China.
Jiang Y; School of Pharmacy, Second Military Medical University, Shanghai 200433, China.; Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China.
Li L; School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Kong X; School of Medicine, Shanghai University, Shanghai 200444, China.
Chen S; School of Medicine, Shanghai University, Shanghai 200444, China.
Hu H; School of Medicine, Shanghai University, Shanghai 200444, China.
Li X; School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2024 Jan 25; Vol. 67 (2), pp. 1360-1369. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Teriparatide*/pharmacology
Teriparatide*/therapeutic use
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Silver/pharmacology ; Glycosylation ; Maltose/pharmacology ; Xylose/pharmacology ; Peptides/pharmacology ; Glucose/pharmacology ; Lactose ; Catalysis ; Bone Density
Czasopismo naukowe
Tytuł:
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
Autorzy:
Clifton Goldney D; Instituto de Diagnostico E Investigaciones Metabólicas (IDIM), Buenos Aires, Argentina.
Pelegrin C; Instituto de Diagnostico E Investigaciones Metabólicas (IDIM), Buenos Aires, Argentina.
Jerkovich F; Instituto de Diagnostico E Investigaciones Metabólicas (IDIM), Buenos Aires, Argentina.
Longobardi V; Instituto de Diagnostico E Investigaciones Metabólicas (IDIM), Buenos Aires, Argentina.; Cátedra de Osteología Y Metabolismo Mineral, Universidad del Salvador, Buenos Aires, Argentina.
Gonzalez Rodriguez E; Interdisciplinary Center for Bone Diseases, Rheumatology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Zanchetta MB; Instituto de Diagnostico E Investigaciones Metabólicas (IDIM), Buenos Aires, Argentina. .; Cátedra de Osteología Y Metabolismo Mineral, Universidad del Salvador, Buenos Aires, Argentina. .
Pokaż więcej
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Jan; Vol. 35 (1), pp. 165-171. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Fractures, Bone*/epidemiology
Spinal Fractures*/complications
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Female ; Humans ; Denosumab/adverse effects ; Teriparatide/therapeutic use ; Zoledronic Acid/therapeutic use ; Follow-Up Studies ; Bone Density
Czasopismo naukowe
Tytuł:
Exploring epigenetic strategies for the treatment of osteoporosis.
Autorzy:
Yi SJ; Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
Lim J; Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
Kim K; Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2024 Mar 08; Vol. 51 (1), pp. 398. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Osteoporosis*/drug therapy
Osteoporosis*/genetics
Osteoporosis*/metabolism
Bone Density Conservation Agents*
Fractures, Bone*/genetics
Humans ; Aged ; Bone Density ; Epigenesis, Genetic
Czasopismo naukowe
Tytuł:
Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis.
Autorzy:
Kong M; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Gao C; Department of Oncology, Qingdao Municipal Hospital, No. 1, Jiao Zhou Road, Qing'dao, 266000, Shandong Province, China.
Luan X; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Fan C; Department of General Surgery, Ankang Hospital of Shandong Province, No. 1, Ji Dai Road, Ji'ning, 272000, Shandong Province, China.
Hao M; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Jin C; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Zhao J; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Li H; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Zhao J; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Luan J; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Lin Y; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China. .
Li Q; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Feb 03; Vol. 25 (1), pp. 109. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*
Osteoporosis*/diagnostic imaging
Osteoporosis*/drug therapy
Gastrointestinal Diseases*
Osteoporosis, Postmenopausal*/diagnostic imaging
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Teriparatide/therapeutic use ; Teriparatide/pharmacology ; Retrospective Studies ; Postmenopause ; Glucocorticoids/therapeutic use ; Bone Density ; Diphosphonates/therapeutic use ; Lumbar Vertebrae/diagnostic imaging
Czasopismo naukowe
Tytuł:
Relationship between polymorphisms and mutations at rs7125942 and rs3736228 of LRP5 gene and bone metabolism in postmenopausal women.
Autorzy:
Li J; Department of Endocrinology and Metabolism, The First Affiliated Hospital, Shihezi University, Shihezi, 832002, Xinjiang, China. .
Li Y; Department of Endocrinology and Metabolism, The First Affiliated Hospital, Shihezi University, Shihezi, 832002, Xinjiang, China.
Li S; Medical School of Shihezi University, Shihezi, 832002, China.
Lu Y; Medical School of Shihezi University, Shihezi, 832002, China.
Rai P; Ocaf Hospital, Karachi, Pakistan.
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Feb 01; Vol. 19 (1), pp. 104. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Low Density Lipoprotein Receptor-Related Protein-5*/genetics
Osteoporosis, Postmenopausal*/genetics
Humans ; Female ; Postmenopause/genetics ; Bone Density/genetics ; Polymorphism, Genetic ; Mutation
Czasopismo naukowe
Tytuł:
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
Autorzy:
Makras P; Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, 3 Kanellopoulou st, 11525, Athens, Greece. .; Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece. .
Yavropoulou MP; Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, 3 Kanellopoulou st, 11525, Athens, Greece.; Εndocrinology Unit, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Polyzos SA; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Papapoulos SE; Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, 3 Kanellopoulou st, 11525, Athens, Greece.; Center for Bone Quality, Department of Internal Medicine, Section Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Georgakopoulou D; Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.
Papatheodorou A; Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, 3 Kanellopoulou st, 11525, Athens, Greece.
Anastasilakis AD; Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
Pokaż więcej
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Feb; Vol. 35 (2), pp. 365-370. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis, Postmenopausal*/drug therapy
Bone Density Conservation Agents*
Bone Resorption*
Humans ; Female ; Animals ; Mice ; Denosumab/pharmacology ; Denosumab/therapeutic use ; Bone Density
Czasopismo naukowe
Tytuł:
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Autorzy:
Ramchand SK; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA. .
Tsai JN; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Lee H; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Sassana-Khadka G; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Jordan M; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Ryan S; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Leder BZ; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Pokaż więcej
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Feb; Vol. 35 (2), pp. 255-263. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis, Postmenopausal*
Female ; Humans ; Alendronate/adverse effects ; Raloxifene Hydrochloride/adverse effects ; Denosumab/pharmacology ; Denosumab/therapeutic use ; Bone Density ; Biomarkers
Czasopismo naukowe
Tytuł:
Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes.
Autorzy:
Vilaca T; Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, University of Sheffield, Sheffield, UK. .; Metabolic Bone Centre - Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK. .
Eastell R; Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło:
Current osteoporosis reports [Curr Osteoporos Rep] 2024 Feb; Vol. 22 (1), pp. 1-10. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Fractures, Bone*/epidemiology
Fractures, Bone*/prevention & control
Fractures, Bone*/complications
Osteoporosis*/drug therapy
Osteoporosis*/complications
Bone Density Conservation Agents*/therapeutic use
Aged ; Humans ; Bone and Bones ; Bone Density
Czasopismo naukowe
Tytuł:
Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis.
Autorzy:
Kim JT; Division of Endocrinology and Metabolism, Department of Internal Medicine, Nowon Eulji University Hospital, Eulji University School of Medicine, Seoul, Korea.
Kim YM; Division of Nephrology, Department of Internal Medicine, Nowon Eulji University Hospital, Eulji University School of Medicine, Seoul, Korea.
Jung KY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Nowon Eulji University Hospital, Eulji University School of Medicine, Seoul, Korea.
Choi H; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Lee SY; Division of Nephrology, Department of Internal Medicine, Nowon Eulji University Hospital, Eulji University School of Medicine, Seoul, Korea.
Kim HJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Nowon Eulji University Hospital, Eulji University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
The Korean journal of internal medicine [Korean J Intern Med] 2024 Jan; Vol. 39 (1), pp. 148-159. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Osteoporosis, Postmenopausal*/chemically induced
Humans ; Female ; Denosumab/adverse effects ; Calcium ; Bone Density ; Vitamin D ; Calcium Carbonate ; Republic of Korea
Czasopismo naukowe
Tytuł:
The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare.
Autorzy:
Liu Y; University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: .
Arora T; Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, USA.
Zhang J; University of Alabama at Birmingham, Birmingham, AL, USA.
Sodhi SK; Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, USA.
Xie F; Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, USA.
Curtis JR; University of Alabama at Birmingham, Birmingham, AL, USA; Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, USA.
Pokaż więcej
Źródło:
Bone [Bone] 2024 Jan; Vol. 178, pp. 116954. Date of Electronic Publication: 2023 Nov 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
COVID-19*
Osteoporosis, Postmenopausal*/drug therapy
United States ; Humans ; Female ; Aged ; Bone Density ; Postmenopause ; Communicable Disease Control ; Medicare
Czasopismo naukowe
Tytuł:
Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study.
Autorzy:
Miyauchi A; Miyauchi Medical Center, Osaka, Japan.
Hamaya E; Amgen K.K., Midtown Tower 9-7-1 Akasaka, Minato-ku, Tokyo, 107-6239, Japan. .
Shimauchi J; Amgen K.K., Midtown Tower 9-7-1 Akasaka, Minato-ku, Tokyo, 107-6239, Japan.
Yoshinaga Y; Amgen K.K., Midtown Tower 9-7-1 Akasaka, Minato-ku, Tokyo, 107-6239, Japan.
Nishi K; Amgen K.K., Midtown Tower 9-7-1 Akasaka, Minato-ku, Tokyo, 107-6239, Japan.
Pokaż więcej
Źródło:
Journal of bone and mineral metabolism [J Bone Miner Metab] 2024 Jan; Vol. 42 (1), pp. 77-89. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Osteoporosis*/complications
Osteoporosis*/drug therapy
Osteoporosis*/chemically induced
Fractures, Bone*/drug therapy
Fractures, Bone*/prevention & control
Fractures, Bone*/chemically induced
Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*/drug therapy
Antibodies, Monoclonal*
Humans ; Female ; Aged ; Aged, 80 and over ; Male ; Teriparatide/therapeutic use ; Japan ; Bone Density ; Diphosphonates/therapeutic use ; Lumbar Vertebrae ; Denosumab/pharmacology ; Denosumab/therapeutic use
Czasopismo naukowe
Tytuł:
What is the role of risedronate in the primary and secondary prevention of fractures associated with osteoporosis in postmenopausal women? A Cochrane review summary with commentary.
Autorzy:
Arman S; Department of Physical Medicine and Rehabilitation, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2024 Jan; Vol. 27 (1), pp. e14940. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Fractures, Bone*/complications
Fractures, Bone*/prevention & control
Osteoporosis*/diagnosis
Osteoporosis*/drug therapy
Osteoporosis*/prevention & control
Osteoporosis, Postmenopausal*/diagnosis
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/prevention & control
Bone Density Conservation Agents*/adverse effects
Female ; Humans ; Risedronic Acid/adverse effects ; Secondary Prevention ; Postmenopause ; Bone Density
Czasopismo naukowe
Tytuł:
Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management.
Autorzy:
Anastasilaki E; School of Medicine, European University of Cyprus, Nicosia, Cyprus.
Paccou J; Univ. Lille, CHU Lille, MABlab ULR 4490, Department of Rheumatology, 59000, Lille, France.
Gkastaris K; Deparment of Endocrinology and Diabetes, St Luke's Hospital, Thessaloniki, Greece.
Anastasilakis AD; Department of Endocrinology, 424 Military General Hospital, Ring Road, 564 29 N. Efkarpia, Thessaloniki, Greece. .
Pokaż więcej
Źródło:
Hormones (Athens, Greece) [Hormones (Athens)] 2023 Dec; Vol. 22 (4), pp. 611-622. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Bone Density Conservation Agents*/pharmacology
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Osteoporosis*/prevention & control
Humans ; Bone Density ; Fractures, Bone/drug therapy ; Glucocorticoids/adverse effects ; Male ; Female
Czasopismo naukowe
Tytuł:
Sustained hypophosphatemia after denosumab in a patient on hemodialysis.
Autorzy:
Almodares AAS; Department of Medicine 1 - Endocrinology- Nephrology and Cardiology, Holbæk Hospital, Holbæk, Denmark.
Elder GJ; Skeletal Biology Program, Garvan Institute of Medical Research, Australia; Department of Renal Medicine, Westmead Hospital, Sydney, Australia.
Abrahamsen B; Department of Medicine 1 - Endocrinology- Nephrology and Cardiology, Holbæk Hospital, Holbæk, Denmark.; Open Patient Data Exploratory Network (OPEN), University of Southern Denmark, Odense, Denmark. Electronic address: .
Pokaż więcej
Źródło:
Bone [Bone] 2024 Apr; Vol. 181, pp. 117045. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hypocalcemia*/chemically induced
Hypophosphatemia*/chemically induced
Renal Insufficiency*/chemically induced
Bone Density Conservation Agents*/adverse effects
Humans ; Male ; Aged, 80 and over ; Denosumab/adverse effects ; Renal Dialysis/adverse effects ; Phosphates ; Bone Density
Czasopismo naukowe
Tytuł:
Efficacy of denosumab on bone metabolism and bone mineral density in renal transplant recipients: A systematic review and meta-analysis.
Autorzy:
Zhu P; Department of Internal Medicine, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, PR China.
Yang T; Department of Respiratory and Critical Care Medicine, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, PR China.
Le J; Orthopedics Department, Hangzhou TCM Hospital Affliated to Zhejiang Chinese Medical University, PR China.
Fu X; Orthopedics Department, Hangzhou TCM Hospital Affliated to Zhejiang Chinese Medical University, PR China.
Zhang L; Orthopedics Department, Hangzhou TCM Hospital Affliated to Zhejiang Chinese Medical University, PR China. Electronic address: .
Pokaż więcej
Źródło:
Transplantation reviews (Orlando, Fla.) [Transplant Rev (Orlando)] 2023 Dec; Vol. 37 (4), pp. 100793. Date of Electronic Publication: 2023 Aug 26.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Hypocalcemia*/etiology
Kidney Transplantation*/adverse effects
Humans ; Bone Density ; Denosumab/therapeutic use
Czasopismo naukowe
Tytuł:
Effect of bedside health education for elderly patients with fragility fracture by specialist physicians on the diagnosis and treatment of osteoporosis during hospitalization and the visiting rate to osteoporosis clinic after discharge in a high-volume orthopedic hospital.
Autorzy:
Yang J; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Tang Q; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Che M; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Shi J; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Yang L; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Zeng Y; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. .
Pokaż więcej
Źródło:
Archives of osteoporosis [Arch Osteoporos] 2023 Nov 13; Vol. 18 (1), pp. 133. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Osteoporosis*/diagnosis
Osteoporosis*/epidemiology
Osteoporosis*/therapy
Osteoporotic Fractures*/diagnosis
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/therapy
Bone Density Conservation Agents*/therapeutic use
Physicians*
Humans ; Aged ; Retrospective Studies ; Patient Discharge ; Bone Density ; Hospitalization ; Health Education ; Hospitals
Czasopismo naukowe
Tytuł:
The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study.
Autorzy:
Dabbaghmanesh A; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Bakhshayeshkaram M; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Roshanzamir S; Department of Physical Medicine and Rehabilitation, Shiraz University of Medical Sciences, Shiraz, Iran.
Naseri A; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Dabbaghmanesh MM; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Heydari ST; Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Talehzadeh P; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Dabbaghmanesh MH; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .
Jahromi SE; Nephrology-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
BMC nephrology [BMC Nephrol] 2023 Nov 08; Vol. 24 (1), pp. 331. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Kidney Transplantation*/adverse effects
Bone Density Conservation Agents*/adverse effects
Humans ; Zoledronic Acid/therapeutic use ; Zoledronic Acid/pharmacology ; Cross-Sectional Studies ; Transplant Recipients ; Femur Neck/diagnostic imaging ; Bone Density ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Recent advance of small-molecule drugs for clinical treatment of osteoporosis: A review.
Autorzy:
Zhang JY; College of Chemistry and Chemical Engineering, Zhengzhou Normal University, Zhengzhou, 450044, China.
Zhong YH; Department of Orthopedics, China-Japan Union Hospital, Jilin University, Changchun, 130033, China; Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University/Liu-Zhou Worker's Hospital, Liuzhou, Guangxi, 545005, China.
Chen LM; Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University/Liu-Zhou Worker's Hospital, Liuzhou, Guangxi, 545005, China.
Zhuo XL; Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University/Liu-Zhou Worker's Hospital, Liuzhou, Guangxi, 545005, China.
Zhao LJ; The Rogel Cancer Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, United States. Electronic address: .
Wang YT; First People's Hospital of Shangqiu, Henan Province, Shangqiu, 476100, China; Department of Orthopedics, China-Japan Union Hospital, Jilin University, Changchun, 130033, China. Electronic address: .
Pokaż więcej
Źródło:
European journal of medicinal chemistry [Eur J Med Chem] 2023 Nov 05; Vol. 259, pp. 115654. Date of Electronic Publication: 2023 Jul 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis*/drug therapy
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Female ; Humans ; Bone Density ; Diphosphonates/pharmacology ; Diphosphonates/therapeutic use ; Selective Estrogen Receptor Modulators/pharmacology
Czasopismo naukowe
Tytuł:
Effects of denosumab on bone mineral density and bone metabolism in patients with end-stage renal disease: A systematic review and meta-analysis.
Autorzy:
Gu Z; Department of Endocrinology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, People's Republic of China.
Yang X; Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China.
Wang Y; Chaoyang 1st Sanitarium for Retired Cadres of Beijing Garrison of the Chinese PLA, Beijing, People's Republic of China.
Gao J; Department of Nephrology, The Chinese PLA Strategic Support Force Characteristic Medical Center, Beijing, People's Republic of China.
Pokaż więcej
Źródło:
Hemodialysis international. International Symposium on Home Hemodialysis [Hemodial Int] 2023 Oct; Vol. 27 (4), pp. 352-363. Date of Electronic Publication: 2023 Jun 01.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Hypocalcemia*/chemically induced
Bone Density Conservation Agents*/pharmacology
Kidney Failure, Chronic*
Humans ; Bone Density ; Denosumab/adverse effects ; Renal Dialysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies